Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Esophagogastric Junction.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07517211
What this trial is testing

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study

Who this might be right for
Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+9 more
Jonsson Comprehensive Cancer Center 72
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06666166
What this trial is testing

SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer

Who this might be right for
Advanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Colorectal Cancer
Yunpeng Liu 28
Testing effectiveness (Phase 2)Looking for participantsNCT06774222
What this trial is testing

Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital 69
Testing effectiveness (Phase 2)Study completedNCT00258323
What this trial is testing

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT07492615
What this trial is testing

A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Fudan University 276
Testing effectiveness (Phase 2)Study completedNCT05394740
What this trial is testing

Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
National Cancer Center Hospital East 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850
What this trial is testing

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Who this might be right for
Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06454435
What this trial is testing

Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 158
Testing effectiveness (Phase 2)Looking for participantsNCT06560528
What this trial is testing

Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04555304
What this trial is testing

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Who this might be right for
Gastric CancerGastroesophageal Cancer
Chengdu Kanghong Biotech Co., Ltd. 81
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Large-scale testing (Phase 3)Study completedNCT04210115
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Gastroesophageal Junction Carcinoma (GEJC)Esophageal Adenocarcinoma (EAC)
Merck Sharp & Dohme LLC 703
Large-scale testing (Phase 3)Looking for participantsNCT04447352
What this trial is testing

HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Krankenhaus Nordwest 200
Large-scale testing (Phase 3)UnknownNCT04435652
What this trial is testing

QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Pharmaceutical Co., Ltd. 492
Not applicableStudy completedNCT06277921
What this trial is testing

Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery

Who this might be right for
Esophageal CancerOesophageal CancerSiewert Type I Adenocarcinoma of Esophagogastric Junction+1 more
P. Herzen Moscow Oncology Research Institute 230
Large-scale testing (Phase 3)UnknownNCT04393584
What this trial is testing

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Stomach NeoplasmsGastrointestinal NeoplasmsDocetaxel+3 more
Blokhin's Russian Cancer Research Center 538
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Testing effectiveness (Phase 2)WithdrawnNCT07283848
What this trial is testing

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma StomachAdenocarcinoma Gastroesophageal Junction
Massachusetts General Hospital
Not applicableUnknownNCT06277908
What this trial is testing

Postoperative Morbidity and Mortality After Gastric Cancer Surgery

Who this might be right for
Gastric CancerSiewert Type III Adenocarcinoma of Esophagogastric JunctionStomach Cancer
P. Herzen Moscow Oncology Research Institute 700
Next Page